Lon Schneider

Lon Schneider, MD, serves as Director of the USC National Institute on Aging Alzheimer’s Disease Research Center clinical core and the USC State of California Alzheimer’s Disease Center. His advisory roles have included senior scientific advisor at the NIMH, on the American Psychiatric Association Committee for Practice Guidelines in Alzheimer’s and Other Dementia, the World Federation of Societies of Biological Psychiatry Task Force on Dementia. He holds a master’s degree in biometry and epidemiology and is a widely sought expert in clinical trials methods and drug development. His work involves development with novel neuroregenerative disese therapeutics, the science of outcomes assessment, and approaches to modeling and clinical trials simulations. He is an associate editor or editorial board member of several publications, including the Cochrane Dementia and Cognitive Improvement Group, Current Alzheimer Research, BMC-Psychiatry, Alzheimer’s & Dementia, The Lancet Neurology, and Clinical Neuropharmacology among others. He serves as editor-in-chief of Alzheimer’s & Dementia: Translational Research and Clinical Interventions; and has authored numerous papers and chapters.